This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gasem, M. H.
Right arrow Articles by van der Meer, J. W. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gasem, M. H.
Right arrow Articles by van der Meer, J. W. M.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, May 2003, p. 1727-1731, Vol. 47, No. 5
0066-4804/03/$08.00+0     DOI: 10.1128/AAC.47.5.1727-1731.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Persistence of Salmonellae in Blood and Bone Marrow: Randomized Controlled Trial Comparing Ciprofloxacin and Chloramphenicol Treatments against Enteric Fever

M. Hussein Gasem,1 Monique Keuter,2* Wil M. V. Dolmans,2 Johanna van der Ven-Jongekrijg,2 Robert Djokomoeljanto,1 and Jos W. M. van der Meer2

Department of Medicine, Dr. Kariadi Hospital, and Faculty of Medicine, Diponegoro University, Semarang, Indonesia,1 Department of General Internal Medicine, University Medical Center St. Radboud, Nijmegen, The Netherlands2

Received 26 September 2002/ Returned for modification 25 November 2002/ Accepted 18 February 2003

We performed a randomized controlled trial involving 55 adult patients with enteric fever to compare ciprofloxacin and chloramphenicol. Blood and bone marrow cultures and cytokine profiles during therapy were done to compare the clinical and bacteriological efficacies of these drugs. All patients were randomly assigned to receive chloramphenicol (500 mg four times a day orally) for 14 days or ciprofloxacin (500 mg twice a day orally) for 7 days. In each treatment group, patients were subsequently randomized to have blood and bone marrow cultured after either 3 or 5 days of treatment. Twenty-seven patients received chloramphenicol, and 28 received ciprofloxacin. The two groups were similar in terms of baseline characteristics. No significant differences in clinical cure and time to defervescence were found. All strains isolated were susceptible to both antibiotics. Although ciprofloxacin was more effective in the elimination of Salmonella enterica serovars Typhi and Paratyphi A from bone marrow than chloramphenicol, there was still an impressive persistence of Salmonella in the bone marrow culture (67%). In the ciprofloxacin-treated patients the suppressed cytokine production capacity showed a trend to normalize earlier than in patients treated with chloramphenicol.

* Corresponding author. Mailing address: Department of General Internal Medicine, University Medical Center St. Radboud, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands. Phone: 31 (24) 361 8819. Fax: 31 (24) 354 1734. E-mail: M.Keuter{at}aig.umcn.nl.

Antimicrobial Agents and Chemotherapy, May 2003, p. 1727-1731, Vol. 47, No. 5
0066-4804/03/$08.00+0     DOI: 10.1128/AAC.47.5.1727-1731.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • VanWert, A. L., Srimaroeng, C., Sweet, D. H. (2008). Organic Anion Transporter 3 (Oat3/Slc22a8) Interacts with Carboxyfluoroquinolones, and Deletion Increases Systemic Exposure to Ciprofloxacin. Mol. Pharmacol. 74: 122-131 [Abstract] [Full Text]  
  • Parry, C. M., Ho, V. A., Phuong, L. T., Bay, P. V. B., Lanh, M. N., Tung, L. T., Tham, N. T. H., Wain, J., Hien, T. T., Farrar, J. J. (2007). Randomized Controlled Comparison of Ofloxacin, Azithromycin, and an Ofloxacin-Azithromycin Combination for Treatment of Multidrug-Resistant and Nalidixic Acid-Resistant Typhoid Fever. Antimicrob. Agents Chemother. 51: 819-825 [Abstract] [Full Text]  
  • Rosales-Reyes, R., Alpuche-Aranda, C., Ramirez-Aguilar, M. d. l. L., Castro-Eguiluz, A. D., Ortiz-Navarrete, V. (2005). Survival of Salmonella enterica Serovar Typhimurium within Late Endosomal-Lysosomal Compartments of B Lymphocytes Is Associated with the Inability To Use the Vacuolar Alternative Major Histocompatibility Complex Class I Antigen-Processing Pathway. Infect. Immun. 73: 3937-3944 [Abstract] [Full Text]  
  • (2003). Ciprofloxacin or Chloramphenicol for Enteric Fever?. JWatch Infect. Diseases 2003: 4-4 [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»